NCT07135037View on ClinicalTrials.gov

Comparison Between Treatments of Oligohydramnios

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 15, 2025

Study Completion Date

December 31, 2025

Conditions
Oligohydramnios
Interventions
DRUG

Sildenafil 25 MG

Sildenafil is a vasodilator drug which improve blood supply to placenta.Therefore, it should improve idiopathic oligohydramnios.

DRUG

L-Arginine, 1000 Mg Oral Tablet

Aminoacid with vasodilator property which improve blood supply to placenta.Therefore, it should improve idiopathic oligohydramnios.

Trial Locations (2)

33513

ACTIVE_NOT_RECRUITING

Kafrelsheikh University Hospital, Kafr ash Shaykh

RECRUITING

Kafrelsheokh university hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER